IGC Pharma (IGC) Long-Term Deferred Tax (2011 - 2019)
IGC Pharma (IGC) posted quarterly Long-Term Deferred Tax of $758000.0 for Q1 2019, up 31.37% year-over-year from $577000.0 in Q1 2018, and up 31.37% quarter-over-quarter from $577000.0 in Q1 2018.
IGC Pharma (IGC) Long-Term Deferred Tax (2011 - 2019) Analysis & Trends
IGC Pharma (IGC) has reported Long-Term Deferred Tax for 8 consecutive years, with $758000.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Long-Term Deferred Tax rose 31.37% year-over-year to $758000.0; the TTM figure through Mar 2019 stood at $758000.0 (up 31.37% YoY), while the FY2019 annual figure was $758000.0, up 31.37% from the prior year.
- Long-Term Deferred Tax grew to $758000.0 in Q1 2019 per IGC's latest filing, from $577000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $758000.0 in Q1 2019 and bottomed at $19000.0 in Q4 2016.
- Historically, Long-Term Deferred Tax has averaged $367611.9 across 4 years, with a median of $337441.0 in 2015.
- Annual changes were most pronounced in 2016 — Long-Term Deferred Tax plunged 93.76% — and 2019, when it soared 31.37%.
- IGC Pharma's Long-Term Deferred Tax stood at $304272.0 in 2015, then slumped by 93.76% to $19000.0 in 2016, then jumped by 2936.84% to $577000.0 in 2018, then jumped by 31.37% to $758000.0 in 2019.
- Business Quant data shows IGC's Long-Term Deferred Tax at $758000.0 in Q1 2019, $577000.0 in Q1 2018, and $19000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 758,000.00 |
| Mar 31, 2018 | 577,000.00 |
| Dec 31, 2016 | 19,000.00 |
| Sep 30, 2016 | 356,619.00 |
| Jun 30, 2016 | 356,334.00 |
| Mar 31, 2016 | 356,684.00 |
| Dec 31, 2015 | 304,272.00 |
| Sep 30, 2015 | 311,509.00 |
| Jun 30, 2015 | 318,153.00 |
| Mar 31, 2015 | 318,548.00 |
| Dec 31, 2014 | 318,159.00 |
| Sep 30, 2014 | 318,625.00 |
| Jun 30, 2014 | 322,451.00 |
| Mar 31, 2014 | 321,676.00 |
| Dec 31, 2013 | 298,635.00 |
| Sep 30, 2013 | 316,233.00 |
| Jun 30, 2013 | 326,237.00 |
| Mar 31, 2013 | 341,455.00 |
| Mar 31, 2012 | -14,076.00 |
| Dec 31, 2011 | 180,929.00 |